Sir David Jack discovered:
- the first beta-2-selective agonist (salbutamol, called albuterol in the U.S.)
- the first inhaled corticosteroid (beclomethasone dipropionate)
- the first long-acting beta-2-agonist (salmeterol)
- the most widely used inhaled corticosteroid (fluticasone propionate)
- the best-selling asthma treatment of all time (Seretide. called Advair in the U.S.).
He also discovered several other important drugs, including the histamine H2-receptor antagonist ranitidine (Zantac), which became the best-selling drug of its day, and sumatriptan (Imigran), a novel therapy for migraine.
David Jack was born in is a small town in Scotland, the sixth and youngest child of a coal miner.
It is extraordinary that the other great drug discoverer of our time, Sir James Black, who went on to discover beta-blockers and histamine H2-receptor antagonists, was born in the same year (1924) in a nearby village.
References:
David Jack (1924–2011) who revolutionised the treatment of asthma. Thorax 2012;67:266-267 doi:10.1136/thoraxjnl-2011-201522
Sir David Jack. The Lancet.
Sir David Jack. The Telegraph.
Sir David Jack: Pioneering chemist who revolutionised the treatment of asthma. The Independent.
Image source: Levosalbutamol (INN) or levalbuterol (USAN), trade name Xopenex, is the R-enantiomer of the short-acting β2-adrenergic receptor agonist albuterol (salbutamol). Wikipedia, public domain.
Comments from Google Plus and Twitter:
Nick Watts, Feb 19, 2012: I can't believe that one man discovered what is basically the entire first couple of steps of the modern treatment for asthma. Thanks for the share.
Dr John Weiner @AllergyNet: Thanks Ves, I was unaware of this. His obit: http://www.telegraph.co.uk/news/obituaries/finance-obituaries/8897458/Sir-David-Jack.html